Skip to content

Blood and blood products transfusion for major surgeries in children.

Peri-operative blood transfusion in major pediatric surgeries and its impact on 30-days mortality- A prospective observational study

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2022/11/047547
Enrollment
250
Registered
2022-11-23
Start date
Unknown
Completion date
Unknown
Last updated
2023-01-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: J982- Interstitial emphysema Health Condition 2: K831- Obstruction of bile duct Health Condition 3: K689- Other disorders of retroperitoneum Health Condition 4: C7A8- Other malignant neuroendocrine tumors Health Condition 5: K928- Other specified diseases of the digestive system Health Condition 6: K766- Portal hypertension Health Condition 7: B948- Sequelae of other specified infectious and parasitic diseases

Interventions

None listed

Sponsors

Postgraduate Institute of Medical Education and Research
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Children posted for all major surgeries under balanced anesthesia for which blood or/and blood products will be arranged. A minimum of 250 such children will be included.

Exclusion criteria

Exclusion criteria: 1. Parental refusal to participate in study. 2. Surgeries under local/regional anesthesia.

Design outcomes

Primary

MeasureTime frame
To study the impact of peri-operative blood transfusion on 30-days mortality in children undergoing major surgical procedures.Timepoint: 30th day

Secondary

MeasureTime frame
1. To determine the transfusion-triggering hemoglobin threshold level in the study participants. 2. To identify the impact of peri-operative blood transfusion and various factors (patient, anesthesia, surgical) on post-operative morbidity (defined as per ACS-NSQIP Convention, hypotension, thrombocytopenia, electrolyte abnormality, hypoglycemia, seizure, active bleed or anastomotic leak) and mortality.Timepoint: 1. Intraoperative (just before starting PRBC). 2. upto 30 days.

Countries

India

Contacts

Public ContactDr Indu M Sen

Postgraduate Institute of Medical Education and Research

indumohini@gmail.com7087009532

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026